U.S. Healthtech Stock News

If you have ever looked at McDonald's and wondered whether a global fast food icon can still be a value play, you are exactly who this breakdown is for. The stock has quietly climbed to around $310.79, with returns of 3.3% over the last week, 3.7% over the last month, 6.2% year to date, 5.8% over 1 year, and 62.1% over 5 years, which naturally raises questions about how much upside is left. Recent headlines have focused on McDonald's ongoing menu innovation and digital initiatives, from...

Wondering if Baidu is a bargain or a value trap at today’s price? Let’s break down what the market is really pricing in and where the opportunity might lie. Baidu’s share price has climbed 4.2% over the last week and is up a hefty 49.9% year to date, even though the last 30 days have been slightly negative at -1.6%. Over the past year it is still sitting on a 38.9% gain, despite only a modest 3 year return of 4.0% and a 5 year loss of -33.2%. Recent moves have been driven by growing optimism...

Robinhood Markets (HOOD) has quietly turned into a big winner for patient investors, with the stock up around 164% over the past year as the business scales and profitability improves. See our latest analysis for Robinhood Markets. That momentum has been fueled by improving fundamentals and growing engagement on the platform, with a robust year to date share price return of 244.09% and a powerful 1-year total shareholder return of 263.25% signaling that sentiment has meaningfully shifted in...

Why Coca-Cola's Valuation Deserves a Closer Look Coca-Cola has long been viewed as a classic defensive stock, but its current share price is raising fresh questions about whether investors are paying up for safety or getting a fair deal. To figure that out, it can help to break down its value using a few different lenses rather than relying on reputation alone. On the surface, Coke still appears to be the steady compounder it has long been, with dependable cash flows and one of the strongest...

If you are wondering whether Thermo Fisher Scientific is still a smart buy at around $563 a share, or if the easy gains are already behind it, this breakdown will help you evaluate what you might really be paying for. The stock is up 7.8% year to date and 5.7% over the last year, but that climb has cooled recently, with a 2.3% dip over the past month and a 3.0% slide in the last week, suggesting that market sentiment is in flux. Investors have been reacting to a mix of headlines around...

FinVolution Group (FINV) is back in the spotlight after fresh coverage underscored its shift to a capital light consumer credit facilitator model, stronger international momentum and management’s renewed confidence in revenue growth into 2025. See our latest analysis for FinVolution Group. Despite the fresh enthusiasm, the stock’s 90 day share price return of negative 32.46% and year to date share price return of negative 23.89% show sentiment is still resetting. At the same time, the five...

Power Solutions International recently reported that its pivot toward higher-growth emission-certified power systems, especially for data centers, has driven substantial increases in 2025 net sales and net income, supported by a revised revolving credit facility and removal of prior going-concern uncertainty. This shift positions the company as a cash-generative integrator benefiting from surging on-site generation needs tied to AI and data-center expansion, creating a clearer operational...

Wondering if Vistra is still worth buying after its massive run, or if most of the upside is already baked into the price? Here is a closer look at what the current share price implies about its future. After an explosive multiyear climb of 613.3% over 3 years and 891.3% over 5 years, the stock has cooled off recently, slipping 4.5% in the last week and 13.7% over the past month, while still sitting on a 10.1% gain year to date and 17.1% over the last year. These moves are happening against...

If you are wondering whether D.R. Horton at around $149 a share is a bargain or a value trap right now, you are not alone, and this breakdown is designed to address exactly that question. The stock is up 121.2% over five years and 76.2% over three years, but more recently it is down 5.7% over the last week, up 3.2% over the last month, and only 8.5% higher year to date. This suggests the market is rethinking its risk and growth expectations. Those swings are happening against a backdrop of...

Coeur Mining (CDE) just kicked off its biggest exploration push at Palmarejo since 2012, and early drilling hits at La Unión, Camuchín, Hidalgo, and San Miguel are quietly reshaping the long term resource picture. See our latest analysis for Coeur Mining. That exploration update lands after a huge run, with Coeur’s share price now at $16.07 and a powerful year to date share price return of 159.19 percent alongside a 1 year total shareholder return of 129.9 percent. This is signalling momentum...

Earlier this week, Erie Indemnity reported third-quarter 2025 results with earnings per share of US$3.50 beating expectations, while revenue came in slightly below analyst estimates and trading conditions were broadly weak. Despite these pressures, the company remains profitable and has maintained an uninterrupted dividend record for 30 consecutive years, underscoring its income-focused appeal. With the share price recently experiencing a 6.27% weekly decline, we’ll consider how the revenue...

Wondering if EPAM Systems at around $208 is a recovery story or a value trap? You are not alone, and this piece is going to dig into what the current price really implies. The stock has bounced about 7.8% over the last week and 18.6% over the past month, even though it is still down 9.2% year to date and 16.8% over the last year, with a much steeper slide of 42.9% over three years and 36.2% over five years. Much of this recent volatility has been tied to shifting sentiment around IT services...

AMC Entertainment Holdings (AMC) has cashed in most of its Hycroft Mining stake, securing roughly $24.1 million in proceeds while keeping a smaller equity position and warrants, signaling a renewed focus on its core theater business. See our latest analysis for AMC Entertainment Holdings. The move to exit most of Hycroft comes after a tough stretch for shareholders, with a year to date share price return of negative 43.28 percent and a 1 year total shareholder return of negative 48.76...

Ensign Group (ENSG) has quietly outperformed many healthcare peers this year, so the stock now invites a closer look at whether its strong long term returns still leave room for further upside. See our latest analysis for Ensign Group. Recent trading has cooled slightly, with a modest pullback from recent highs even as Ensign holds near $174.14. However, the 90 day share price return and multi year total shareholder returns still point to sustained momentum rather than a reversal. If Ensign’s...

If you are wondering whether Summit Therapeutics is still worth a closer look after its big run, or if you would just be buying into yesterday's hype, this article will walk you through what the current price really implies. Summit has cooled off recently, with the stock up 1.4% over the last week and 1.8% over the past month. However, that sits on top of a 469.6% gain over three years and 235.6% over five years, even though the 1 year return is slightly negative at 0.8%. Those moves have...

Recently, analysts have raised their earnings estimates for AvePoint, and the stock has received a top Zacks Rank, reflecting stronger confidence in its profit outlook. This shift follows an earlier post-earnings setback highlighted by Voya Investment Management, underscoring how changing sentiment and short interest trends can rapidly reshape perceptions of AvePoint’s prospects. Next, we’ll examine how this renewed analyst optimism around AvePoint’s earnings outlook influences the company’s...

Lands' End (LE) has just posted Q3 2026 results with revenue of about $317.5 million and basic EPS of $0.17, putting a clear profit on the board for the quarter. The company has seen quarterly revenue hold around the low $300 million mark over the last few periods, while basic EPS has swung from losses of roughly $0.27 and $0.17 earlier in 2026 to a modest profit this quarter, setting up a story that is increasingly about how much of that top line can translate into sustainable margins. See...

Bristol-Myers Squibb (BMY) has quietly pushed higher over the past month, even as its longer term returns remain underwhelming. That mix of recent momentum and lagging history is exactly what makes the stock interesting now. See our latest analysis for Bristol-Myers Squibb. Over the past year, Bristol-Myers Squibb’s share price return has been negative, but the recent 1 month and 3 month share price gains suggest sentiment is cautiously improving as investors reassess its pipeline and...

Amer Sports (NYSE:AS) has quietly put together a strong run, with the stock climbing about 34% year to date and roughly 51% over the past year as revenue and earnings growth pick up. See our latest analysis for Amer Sports. That move has been reinforced by a sharp 30 day share price return of about 31% and a 1 year total shareholder return just over 50%, suggesting momentum is building as investors lean into its growth story. If Amer Sports’ run has you thinking about what else could surprise...

If you are wondering whether Papa John's International at around $40.96 is a quietly mispriced opportunity or a value trap in plain sight, this breakdown is for you. The stock is down about 2.8% over the last week, roughly flat over the past month, and still sitting on a 10.5% slide over the past year and a steep 48.2% drop over three years, which indicates sentiment has been under pressure for a while. Recent headlines have focused on Papa John's ongoing strategy tweaks, from sharpening its...

DigitalOcean Holdings (DOCN) is back in focus after its Paperspace acquisition, a deal aimed squarely at beefing up AI infrastructure just as the company more than doubled its direct AI revenue and locked in extra data center capacity. See our latest analysis for DigitalOcean Holdings. That AI push seems to be resonating, with the 90 day share price return of 45.42 percent and a 1 year total shareholder return of 29.85 percent signalling that momentum is building rather than fading. If you...

How Has IBM Stock Been Performing Lately International Business Machines has been on many investors watchlists lately, raising the question of whether its current share price offers real value or if most of the upside has already been captured. With a long history and a renewed focus on hybrid cloud and AI, IBM is again at the center of the value versus growth debate. Over the last year, IBM shares have delivered a strong 37.5% return, with gains of 2.9% over the past week and 1.3% over the...

In late November 2025, Alibaba launched its Quark AI Glasses line in China, offering S1 and G1 models priced from ¥3,799 and ¥1,899, tightly integrated with its Qwen AI model, Qwen App, and core platforms like Alipay, Amap, Taobao, Fliggy, and major music services. This move shows how Alibaba is pushing Qwen beyond the cloud and into everyday consumer hardware, potentially deepening user engagement across its wider digital ecosystem. We’ll now examine how Alibaba’s push into Qwen-powered...

Analyst Downgrade Sparks Fresh Scrutiny Of Kohl's Stock Kohl's (KSS) slipped about 3% after a fresh analyst consensus tagged the stock with a Sell rating, pointing to expected drops in comparable and net sales alongside thinning cash reserves. See our latest analysis for Kohl's. Despite the downgrade, Kohl's recent 30 day share price return of 37.6% and roughly 67% year to date gain suggest strong short term momentum. However, the five year total shareholder return remains negative,...